Smallpox Vaccine
Sponsors
Ujiie Mugen, National Institute of Allergy and Infectious Diseases (NIAID), Bristol-Myers Squibb
Conditions
HIV InfectionsMonkeypox
Monkeypox
Phase 1
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)
CompletedNCT00000767
End: 1996-07-31Target: 18Updated: 2021-10-28
A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers
CompletedNCT00002261
Updated: 2007-09-26
A study to evaluate the immunogenicity and safety of smallpox vaccine as vaccination to monkeypox in healthy adults
Active, not recruitingJPRN-jRCTs031220171
Start: 2022-07-04Target: 50Updated: 2025-07-18